| Kathryn Mariana Litt, MD | |
|
3740 W Sylvania Ave, # 103, Toledo, OH 43623-4461 | |
| (419) 473-6622 | |
| (419) 476-6627 |
| Full Name | Kathryn Mariana Litt |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 13 Years |
| Location | 3740 W Sylvania Ave, Toledo, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891094082 | NPI | - | NPPES |
| 0126123 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35126600 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Promedica Toledo Hospital | Toledo, OH | Hospital |
| Bay Park Community Hospital | Oregon, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Promedica Central Physicians | 2365348190 | 818 |
News Archive
An experimental procedure marks the launch of a research study approved by the Food and Drug Administration in January. The breakthrough technology could save the lives of thousands of people with heart valve disease who have no other treatment options. In a new clinical trial the first U.S. patient has received a heart valve implant without open-heart surgery.
Stempeutics Research, a group company of Manipal Education & Medical Group and a joint venture with Cipla Group, announced today that the European Medicines Agency (EMA) has granted Orphan Drug Designation for its drug Stempeucel® for the treatment of Thromboangiitis Obliterans.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
Jamaica's National Family Planning Board in the next few weeks plans to launch a new female condom in an effort to provide women with increased control over HIV/AIDS prevention methods, the Jamaica Gleaner reports.
United American Healthcare Corporation today announced that the Company has entered into an agreement with St. George Investments, LLC, under which St. George has agreed to withdraw its own slate of candidates for the UAHC Board of Directors and vote in favor of the candidates nominated by UAHC's Board at the Annual Meeting of Shareholders scheduled to be held on April 23, 2010.
› Verified 7 days ago
| Entity Name | Promedica Central Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043270150 PECOS PAC ID: 2365348190 Enrollment ID: O20031211000226 |
News Archive
An experimental procedure marks the launch of a research study approved by the Food and Drug Administration in January. The breakthrough technology could save the lives of thousands of people with heart valve disease who have no other treatment options. In a new clinical trial the first U.S. patient has received a heart valve implant without open-heart surgery.
Stempeutics Research, a group company of Manipal Education & Medical Group and a joint venture with Cipla Group, announced today that the European Medicines Agency (EMA) has granted Orphan Drug Designation for its drug Stempeucel® for the treatment of Thromboangiitis Obliterans.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
Jamaica's National Family Planning Board in the next few weeks plans to launch a new female condom in an effort to provide women with increased control over HIV/AIDS prevention methods, the Jamaica Gleaner reports.
United American Healthcare Corporation today announced that the Company has entered into an agreement with St. George Investments, LLC, under which St. George has agreed to withdraw its own slate of candidates for the UAHC Board of Directors and vote in favor of the candidates nominated by UAHC's Board at the Annual Meeting of Shareholders scheduled to be held on April 23, 2010.
› Verified 7 days ago
| Entity Name | The Toledo Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407854771 PECOS PAC ID: 2961309638 Enrollment ID: O20031218001042 |
News Archive
An experimental procedure marks the launch of a research study approved by the Food and Drug Administration in January. The breakthrough technology could save the lives of thousands of people with heart valve disease who have no other treatment options. In a new clinical trial the first U.S. patient has received a heart valve implant without open-heart surgery.
Stempeutics Research, a group company of Manipal Education & Medical Group and a joint venture with Cipla Group, announced today that the European Medicines Agency (EMA) has granted Orphan Drug Designation for its drug Stempeucel® for the treatment of Thromboangiitis Obliterans.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
Jamaica's National Family Planning Board in the next few weeks plans to launch a new female condom in an effort to provide women with increased control over HIV/AIDS prevention methods, the Jamaica Gleaner reports.
United American Healthcare Corporation today announced that the Company has entered into an agreement with St. George Investments, LLC, under which St. George has agreed to withdraw its own slate of candidates for the UAHC Board of Directors and vote in favor of the candidates nominated by UAHC's Board at the Annual Meeting of Shareholders scheduled to be held on April 23, 2010.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn Mariana Litt, MD 1 Seagate, # 800, Toledo, OH 43604-1558 Ph: (567) 585-1969 | Kathryn Mariana Litt, MD 3740 W Sylvania Ave, # 103, Toledo, OH 43623-4461 Ph: (419) 473-6622 |
News Archive
An experimental procedure marks the launch of a research study approved by the Food and Drug Administration in January. The breakthrough technology could save the lives of thousands of people with heart valve disease who have no other treatment options. In a new clinical trial the first U.S. patient has received a heart valve implant without open-heart surgery.
Stempeutics Research, a group company of Manipal Education & Medical Group and a joint venture with Cipla Group, announced today that the European Medicines Agency (EMA) has granted Orphan Drug Designation for its drug Stempeucel® for the treatment of Thromboangiitis Obliterans.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
Jamaica's National Family Planning Board in the next few weeks plans to launch a new female condom in an effort to provide women with increased control over HIV/AIDS prevention methods, the Jamaica Gleaner reports.
United American Healthcare Corporation today announced that the Company has entered into an agreement with St. George Investments, LLC, under which St. George has agreed to withdraw its own slate of candidates for the UAHC Board of Directors and vote in favor of the candidates nominated by UAHC's Board at the Annual Meeting of Shareholders scheduled to be held on April 23, 2010.
› Verified 7 days ago
Nadine C Kassis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3425 Executive Pkwy, Suite 108, Toledo, OH 43606 Phone: 419-214-3192 | |
Anthony J. Armstrong, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4126 N Holland Sylvania Rd, Suite 220, Toledo, OH 43623 Phone: 419-517-7600 Fax: 419-517-7598 | |
Luigi O D'amato, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3740 W Sylvania Ave, Suite 103, Toledo, OH 43623 Phone: 419-473-6622 Fax: 419-473-6627 | |
Lance A Talmage, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2150 W Central Ave, Toledo, OH 43606 Phone: 419-291-2200 Fax: 419-479-3297 | |
Dr. Sonyoung Seo-patel, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2150 W Central Ave, Toledo, OH 43606 Phone: 419-291-2192 Fax: 419-479-3297 | |
Dr. Kathryn Shannon Maloy, M.D., MPH Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2213 Cherry St, Toledo, OH 43608 Phone: 419-251-3232 Fax: 419-251-3997 | |
Tiberiu S. Avram, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3020 N Mccord Rd Ste 201a, Toledo, OH 43615 Phone: 419-517-7727 Fax: 419-517-5036 |